RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Bellerophon Therapeutics
(Updated on Mar 27, 2024)

Buy candidate since Mar 25, 2024 Loss -5.15% PDF

The Bellerophon Therapeutics stock price fell by -1.60% on the last day (Wednesday, 27th Mar 2024) from $0.0577 to $0.0568. During the last trading day the stock fluctuated 5.02% from a day low at $0.0541 to a day high of $0.0568. The price has fallen in 6 of the last 10 days but is still up by 8.63% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 1 thousand shares were bought and sold for approximately $60.56 .

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.58% during the next 3 months and, with a 90% probability hold a price between $0.0441 and $0.0780 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLPH Signals & Forecast

The Bellerophon Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0555 and $0.0544. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, January 22, 2024, and so far it has fallen -14.56%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Bellerophon Therapeutics stock

Bellerophon Therapeutics finds support from accumulated volume at $0.0550 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0027 between high and low, or 5.02%. For the last week the stock has had daily average volatility of 9.65%.

Our recommended stop-loss: $0.0534 (-5.96%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 46 days ago.)

Trading Expectations (BLPH) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Bellerophon Therapeutics to open at $0.0559, and during the day (based on 14 day Average True Range), to move between $0.0517 and $0.0619, which gives a possible trading interval of +/-$0.0051 (+/-8.96%) up or down from last closing price. If Bellerophon Therapeutics takes out the full calculated possible swing range there will be an estimated 17.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0573 (0.85%) than the support at $0.0550 (3.19%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bellerophon Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bellerophon Therapeutics stock to perform well in the short-term.

Current score: 2.493 Buy Candidate Unchanged

Predicted Opening Price for Bellerophon Therapeutics of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.0559 ( 1.59%) $0.0568

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0586 3.19 %
R2 0.0576 1.36 %
R1 0.0569 0.233 %
Current price: 0.0568
Support S1 0.0549 -3.42 %
S2 0.0542 -4.55 %
S3 0.0532 -6.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0640 12.65 %
R2 0.0590 3.85 %
R1 0.0573 0.85 %
Current price 0.0568
Support S1 0.0550 -3.19%
S2 0.0510 -10.23%
S3 0.0430 -24.32%

FAQ

What is the symbol for Bellerophon Therapeutics Stock and on which exchange is it traded?
The symbol for Bellerophon Therapeutics is BLPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bellerophon Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bellerophon Therapeutics stock to perform well in the short-term.

How to buy Bellerophon Therapeutics Stock?
Bellerophon Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bellerophon Therapeutics Stock.

What's the current price of Bellerophon Therapeutics Stock?
As of the end of day on the 2024-03-27, the price of an Bellerophon Therapeutics (BLPH) share was $0.0568.

What is the 52-week high and low for Bellerophon Therapeutics Stock?
The 52-week high for Bellerophon Therapeutics Stock is $12.58 and the 52-week low is $0.0290.

What is the market capitalization of Bellerophon Therapeutics Stock?
As of the 2024-03-27, the market capitalization of Bellerophon Therapeutics is 694.995K.

When is the next earnings date for Bellerophon Therapeutics?
The upcoming earnings date for Bellerophon Therapeutics is Mar 29, 2024.
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT